Italian oncology centers report bladder cancer survival rates aligned with global standards. Five-year survival ranges between 60% and 70% for muscle-invasive cases when lymph nodes are negative. Specialized facilities in Milan and Rome utilize advanced robotic surgery and immunotherapy to manage recurrence risks effectively.
- Treatment options: Surgeons offer robotic cystectomy, Bacillus Calmette-Guerin (BCG) therapy, and HIPEC procedures.
- Specialist expertise: Dr. Francesco Montorsi has performed 8,000+ urological procedures and authored 1,000+ papers.
- Research accreditation: IRCCS certification at San Donato Hospital confirms integration of clinical research and assistance.
- Advanced diagnostics: Clinics utilize PET/CT and complex diagnosis protocols to monitor for potential recurrence.
Bookimed Expert Insight: Italian urological expertise is exceptionally concentrated in Milan. Dr. Francesco Montorsi at San Raffaele has performed over 8,000 procedures. This high volume, combined with his recognition as a top global researcher, suggests that Italian centers offer surgical precision comparable to the best American or British academic hospitals.
Patient Consensus: Patients note that recurrence risks match global statistics, but they highly value the frequent cystoscopy follow-up schedules provided in Italy. Many emphasize that while local medication shortages occur, the surgical outcomes for advanced stages remains consistently high.